PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) will report second-quarter 2026 financial results after the market closes Aug. 12 and provide investors with a broader business update later that afternoon as the biotechnology company advances its DNA-medicine programs.
The company will host a conference call and webcast at 4:30 p.m. ET following the earnings release. The event will be listen-only for the public and will include a live question-and-answer session with analysts.
Investors can access the webcast at http://ir.inovio.com/events-and-presentations/default.aspx. A replay will remain available for 90 days.
INOVIO develops DNA medicines targeting HPV-related diseases, cancer and infectious diseases. Its technology is designed to deliver DNA instructions that prompt the body to produce disease-fighting proteins.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.